Zobrazeno 61 - 70
of 101
pro vyhledávání: '"Irene Hramiak"'
Autor:
Jeffrey L. Mahon, Lewis W Mahon, David C. Schulz, Selina L. Liu, Neil Klar, Irene Hramiak, John R. Gonder
Publikováno v:
BMJ Open
IntroductionSuboptimal screening for diabetic eye disease is a major cause of preventable vision loss. Screening barriers include mydriasis and the extra time patients need to attend dedicated eye screening appointments. In the Clearsight trial, we a
Autor:
David J. Brillon, Debra L. Simmons, Zubin Punthakee, Hertzel C. Gerstein, Joseph Largay, Richard M. Bergenstal, Irene Hramiak, Ajay Sood, Peter J. Savage, Michael E. Miller, Faramarz Ismail-Beigi, Matthew C. Riddle
Publikováno v:
Diabetologia. 57(10)
We aimed to determine the persistence of glycaemic control 1 year after a limited period of intensive glycaemic management of type 2 diabetes.4119 ACCORD Trial participants randomised to target HbA1c6.0% (42 mmol/mol) for 4.0 ± 1.2 years were system
Autor:
Ian G. Stiell, Marco L.A. Sivilotti, Vincent Woo, Marc Afilalo, Jean-François Yale, Marcia L. Edmonds, Eddy Lang, Jennifer Riley, Irene Hramiak, Frank X. Scheuermeyer, Lawrence A. Leiter, Mira Singh, Samuel G Campbell, Brian H. Rowe, Cristina Villa-Roel, Andrew Worster
Publikováno v:
Paediatrics Publications
Objectifs: Cette vérification rétrospective des dossiers a permis d'examiner les données démographiques, les examens, la prise en charge et les résultats des patients adultes souffrant de diabète sucré qui se sont présentés aux services des
Autor:
Ronen Gurfinkel, Irene Hramiak, Selina L. Liu, Jeffrey L. Mahon, Tamara Spaic, Stewart B. Harris, Michael Weingert
Publikováno v:
Canadian Journal of Diabetes. 40:S8
Publikováno v:
Diabetes Care. 20:381-384
OBJECTIVE To determine whether a subcutaneous injection of truncated glucagon-like peptide 1 (tGLP-I)(7–36) amide that delays gastric emptying transiently can prevent postcibal hyperglycemia in IDDM without causing hypoglycemia when administered wi
Autor:
Irene Hramiak, John Dupre, Margaret T. Behme, P McFarlane, M P Williamson, P. Zabel, Thomas J. McDonald
Publikováno v:
Diabetes. 44:626-630
Effects of human glucagon-like peptide I (GLP-I)(7–36)amide were examined in volunteers having insulin-dependent diabetes mellitus (IDDM) with residual C-peptide (CP) secretion (n = 8, 7 men and 1 woman; age, 31 ± 1.4 years; body mass index, 24.7
Autor:
Margaret T. Behme, Thomas J. McDonald, E. Tu, C. Panchal, W. B. Barnett, Irene Hramiak, S. Brenner, D. Miller, John Dupre, P. Zabel
Publikováno v:
American Journal of Physiology-Endocrinology and Metabolism. 266:E612-E617
Previous studies demonstrated that porcine galanin is a potent inhibitor of insulin secretion in many species but fails to alter human insulin secretion. To resolve whether this discrepancy was due to the use of a heterologous peptide or to a true sp
Autor:
Patrick J. O'Connor, Timothy E. Craven, Ulrich K. Schubart, William C. Cushman, Jorge Calles-Escandon, Irene Hramiak, Lois A. Katz, Jeffrey L. Probstfield, Faramarz Ismail-Beigi, Saul Genuth, Diane M. Karl, Hertzel C. Gerstein
Publikováno v:
Kidney international. 81(6)
A reduction of either blood pressure or glycemia decreases some microvascular complications of type 2 diabetes, and we studied here their combined effects. In total, 4733 older adults with established type 2 diabetes and hypertension were randomly as
Autor:
Faramarz, Ismail-Beigi, Timothy, Craven, Mary Ann, Banerji, Jan, Basile, Jorge, Calles, Robert M, Cohen, Robert, Cuddihy, William C, Cushman, Saul, Genuth, Richard H, Grimm, Bruce P, Hamilton, Byron, Hoogwerf, Diane, Karl, Lois, Katz, Armand, Krikorian, Patrick, O'Connor, Rodica, Pop-Busui, Ulrich, Schubart, Debra, Simmons, Harris, Taylor, Abraham, Thomas, Daniel, Weiss, Irene, Hramiak, R, Morrissey
Hyperglycaemia is associated with increased risk of cardiovascular complications in people with type 2 diabetes. We investigated whether reduction of blood glucose concentration decreases the rate of microvascular complications in people with type 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f5d3c10bfdf1001c7f4789c597f7d0a
https://europepmc.org/articles/PMC4123233/
https://europepmc.org/articles/PMC4123233/
Autor:
Luc Sagnard, Antonio Ceriello, Denis Raccah, Pierre Gourdy, Julio Rosenstock, Irene Hramiak, Jay Lin
Publikováno v:
Canadian Journal of Diabetes. 37:S37-S38